TER Teradyne Inc.

Roy Vallee to Retire from Teradyne’s Board of Directors in 2021

Roy Vallee to Retire from Teradyne’s Board of Directors in 2021

NORTH READING, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- (NASDAQ:TER) announced today that Roy Vallee, Teradyne Chairman of the Board of Directors and a member of the Compensation, and Nominating and Governance Committees, will retire from the Board effective at the 2021 annual meeting of shareholders that is expected to be held in May 2021. Mr. Vallee will serve out the remainder of his term as Chair and the Board will elect a new Chair following the 2021 annual meeting of shareholders.

“Roy is a tremendous Board member whose leadership and wise counsel for over 20 years, the last six as Board Chair, have enabled Teradyne to thrive and grow,” said Mark Jagiela, Teradyne President and CEO. “His business acumen, integrity, and high standards have been valuable assets to the Board and our executive team. We thank Roy for his years of service and wish him well in his future pursuits.”

About Teradyne

 (NASDAQ:TER) brings high-quality innovations such as smart devices, life-saving medical equipment and data storage systems to market, faster. Its advanced test solutions for semiconductors, electronic systems, wireless devices and more ensure that products perform as they were designed. Its Industrial Automation offerings include collaborative and mobile robots that help manufacturers of all sizes improve productivity and lower costs. In 2019, Teradyne had revenue of $2.3 billion and today employs 5,500 people worldwide. For more information, visit . Teradyne® is a registered trademark of Teradyne, Inc. in the U.S. and other countries.

For more information, contact:



Andy Blanchard

Investor Relations

Tel 978.370.2425

EN
10/11/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Teradyne Inc.

Pelham Smithers
  • Pelham Smithers

PSA Technology: Advantest (6857 JT) Update Following Teradyne (TER US)...

As Pelham Smithers noted in his review on Advantest’s blowout earnings [28 Oct], we were waiting to see the results from Teradyne for a readacross to the Advantests future performance and concludes that while it is possible that Teradyne’s 2025 Q4 guidance implies a market share gain, there’s a decent chance that it is another blowout quarter for Advantest.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch